CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency. The purpose of this amendment is to increase the reimbursement for COVID-19 vaccines and boosters from $40 to $65, effective back to April 1, 2021, and to allow pharmacists to administer Monoclonal Antibodies (mAbs) therapy for COVID-19 to possibly avoid hospitalization.
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media